Advanced search
Publication Cover
Current Medical Research and Opinion Volume 25, 2009 - Issue 12
Submit an article Journal homepage
497
Views
8
CrossRef citations to date
0
Altmetric
Review

Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150 mg and risedronate 150 mg

S. Epstein Mt Sinai Medical Center, New York, USA and Endocrine Associates Abington Hospital, Pennsylvania, USACorrespondence[email protected]
,
M. Jeglitsch GlaxoSmithKline, Munich, Germany
&
E. McCloskey Metabolic Bone Centre, Northern General Hospital, Sheffield, UK
Pages 2951-2960 | Accepted 23 Sep 2009, Published online: 16 Oct 2009

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Maurizio Rossini, Giovanni Orsolini, Silvano Adami, Vidya Kunnathully & Davide Gatti. (2013) Osteoporosis treatment: why ibandronic acid?. Expert Opinion on Pharmacotherapy 14:10, pages 1371-1381.
Read now

Articles from other publishers (7)

Ju Hwan Kim, Han Eol Jeong, Yeon-Hee Baek, Sun Wook Cho, Hyuna Lim & Ju-Young Shin. (2021) Treatment pattern in postmenopausal women with osteoporosis: a population-based cohort study in South Korea. Journal of Bone and Mineral Metabolism 40:1, pages 109-119.
Crossref
N.V. Grygorievа. (2021) Ефективність та безпечність ібандронової кислоти: фокус на результати рандомізованих досліджень і метааналізів. PAIN, JOINTS, SPINE 9:1, pages 36-45.
Crossref
Michael R. McClung & Frank H. Ebetino. (2020) History of risedronate. Bone 137, pages 115407.
Crossref
Dagan Cloutier. (2015) Osteoporosis. JBJS Journal of Orthopaedics for Physician Assistants 3:3, pages 18-31.
Crossref
François-Emery Cotté & Gérard De Pouvourville. (2011) Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France. BMC Health Services Research 11:1.
Crossref
Silvano Adami, Luca Idolazzi & Maurizio Rossini. (2011) Evidence of Sustained Vertebral and Nonvertebral Antifracture Efficacy with Ibandronate Therapy: A Systematic Review. Therapeutic Advances in Musculoskeletal Disease 3:2, pages 67-79.
Crossref
Young Ho LeeGwan Gyu Song. (2011) Efficacy and Safety of Monthly 150 mg Oral Ibandronate in Women with Postmenopausal Osteoporosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. The Korean Journal of Internal Medicine 26:3, pages 340.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.